Efficacy and safety of three antiretroviral therapy regimens for treatment-naive African adults living with HIV-2 (FIT-2): a pilot, phase 2, non-comparative, open-label, randomised controlled trial.

Eholie SP, Ekouevi DK, Chazallon C, Charpentier C, Messou E, Diallo Z, Zoungrana J, Minga A, Ngom Gueye NF, Hawerlander D, Dembele F, Colin G, Tchounga B, Karcher S, Le Carrou J, Tchabert-Guié A, Toni TD, Ouédraogo AS, Bado G, Toure Kane C, Seydi M, Poda A, Mensah E, Diallo I, Drabo YJ, Anglaret X, Brun-Vezinet F, FIT-2 study group

Open source

DOI: 10.1016/s2352-3018(24)00085-7
Published: 2024 Jun
Container: The lancet. HIV
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s2352-3018-24-00085-7,
  title = {Efficacy and safety of three antiretroviral therapy regimens for treatment-naive African adults living with HIV-2 (FIT-2): a pilot, phase 2, non-comparative, open-label, randomised controlled trial.},
  author = {Eholie SP and Ekouevi DK and Chazallon C and Charpentier C and Messou E and Diallo Z and Zoungrana J and Minga A and Ngom Gueye NF and Hawerlander D and Dembele F and Colin G and Tchounga B and Karcher S and Le Carrou J and Tchabert-Guié A and Toni TD and Ouédraogo AS and Bado G and Toure Kane C and Seydi M and Poda A and Mensah E and Diallo I and Drabo YJ and Anglaret X and Brun-Vezinet F and FIT-2 study group},
  year = {2024},
  journal = {The lancet. HIV},
  doi = {10.1016/s2352-3018(24)00085-7},
  url = {https://doi.org/10.1016/s2352-3018(24)00085-7}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of three antiretroviral therapy regimens for treatment-naive African adults living with HIV-2 (FIT-2): a pilot, phase 2, non-comparative, open-label, randomised controlled trial.
AU  - Eholie SP
AU  - Ekouevi DK
AU  - Chazallon C
AU  - Charpentier C
AU  - Messou E
AU  - Diallo Z
AU  - Zoungrana J
AU  - Minga A
AU  - Ngom Gueye NF
AU  - Hawerlander D
AU  - Dembele F
AU  - Colin G
AU  - Tchounga B
AU  - Karcher S
AU  - Le Carrou J
AU  - Tchabert-Guié A
AU  - Toni TD
AU  - Ouédraogo AS
AU  - Bado G
AU  - Toure Kane C
AU  - Seydi M
AU  - Poda A
AU  - Mensah E
AU  - Diallo I
AU  - Drabo YJ
AU  - Anglaret X
AU  - Brun-Vezinet F
AU  - FIT-2 study group
PY  - 2024
JO  - The lancet. HIV
DO  - 10.1016/s2352-3018(24)00085-7
UR  - https://doi.org/10.1016/s2352-3018(24)00085-7
ER  -

APA

SP, E., DK, E., C, C., C, C., E, M., Z, D., J, Z., A, M., NF, N. G., D, H., F, D., G, C., B, T., S, K., J, L. C., A, T., TD, T., AS, O., G, B., C, T. K., M, S., A, P., E, M., I, D., YJ, D., X, A., F, B., & group, F. S. (2024). Efficacy and safety of three antiretroviral therapy regimens for treatment-naive African adults living with HIV-2 (FIT-2): a pilot, phase 2, non-comparative, open-label, randomised controlled trial.. The lancet. HIV. https://doi.org/10.1016/s2352-3018(24)00085-7

Source records

pubmed · retrieved 2026-09-26T23:01:50.281Z
europe-pmc · retrieved 2026-09-26T23:01:50.292Z
hal · retrieved 2026-09-26T23:01:50.306Z